Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. ZHONG

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

Cancer Research

English

Related publications

BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers

Molecular Cancer Therapeutics

Cancer Research

English

Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701

Cancer Research

English

Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- And Radio-Sensitivity in Nasopharyngeal Carcinoma

Multidisciplinary

English

VEGFR2 Targeted Antibody Fused With MICA Stimulates NKG2D Mediated Immunosurveillance and Exhibits Potent Anti-Tumor Activity Against Breast Cancer

English

GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer

Cancer Research

Gastroenterology

English

Nucleosome‑binding Protein HMGN2 Exhibits Antitumor Activity in Oral Squamous Cell Carcinoma

Oncology Letters

Cancer Research

English

P2.13-32 TAK-788 Is a Novel and Potent Tyrosine Kinase Inhibitor With Selective Activity Against EGFR/HER2

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.13-44 Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Characterization of a Novel PERK Kinase Inhibitor With Antitumor and Antiangiogenic Activity

Cancer Research

Cancer Research

English